Diaceutics PLC (AIM:DXRX)
London · Delayed Price · Currency is GBP · Price in GBX 162.00
0.00 (0.00%)
Oct 10, 2025, 4:42 PM GMT+1
Diaceutics Market Cap
Diaceutics has a market cap or net worth of 137.10 million as of October 10, 2025. Its market cap has increased by 21.57% in one year.
Market Cap
137.10M
Enterprise Value
127.85M
Revenue
34.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
162.00
Market Cap Chart
Since March 21, 2019, Diaceutics's market cap has increased from 66.45M to 137.10M, an increase of 106.31%. That is a compound annual growth rate of 11.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 137.10M | 29.26% |
| Dec 31, 2024 | 106.07M | 44.67% |
| Dec 29, 2023 | 73.32M | 15.14% |
| Dec 30, 2022 | 63.68M | -25.74% |
| Dec 31, 2021 | 85.75M | -23.60% |
| Dec 31, 2020 | 112.23M | 58.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 21, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 200.66B |
| GSK plc | 65.98B |
| Haleon | 30.29B |
| Smith & Nephew | 11.51B |
| ConvaTec Group | 4.86B |
| Hikma Pharmaceuticals | 4.10B |
| HUTCHMED (China) | 1.99B |
| Genus | 1.75B |